Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia
Top Cited Papers
- 6 February 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (5), 634-637
- https://doi.org/10.1161/01.cir.103.5.634
Abstract
Background—We investigated the therapeutic potential of ex vivo expanded endothelial progenitor cells (EPCs) for myocardial neovascularization. Methods and Results—Peripheral blood mononuclear cell...Keywords
This publication has 9 references indexed in Scilit:
- Enhancement of Angiogenesis by the Implantation of Self Bone Marrow Cells in a Rat Ischemic Heart ModelJournal of Surgical Research, 2000
- Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000
- Ascending Aortic Replacement With Aortic Valve ReimplantationCirculation, 1999
- Gene therapy with vascular endothelial growth factor for inoperable coronary artery diseaseThe Annals of Thoracic Surgery, 1999
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cellsThe EMBO Journal, 1999
- Evidence for Circulating Bone Marrow-Derived Endothelial CellsBlood, 1998
- Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heartNature Medicine, 1996
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989